The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients
Article first published online: 7 OCT 2009
Copyright © 2009 Wiley-Liss, Inc.
Pediatric Blood & Cancer
Volume 54, Issue 2, pages 238–241, February 2010
How to Cite
Bleyer, A. (2010), The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients. Pediatr. Blood Cancer, 54: 238–241. doi: 10.1002/pbc.22190
- Issue published online: 8 DEC 2009
- Article first published online: 7 OCT 2009
- Manuscript Accepted: 9 JUN 2009
- Manuscript Received: 8 SEP 2008
- Aflac Foundation
- adolescent cancer;
- adult oncology;
- pediatric oncology;
- treatment site
Data from the State of Georgia suggest that pediatric cancers have better survival outcomes when treated at pediatric cancer centers that are members of the nation's Children's Oncology Group (COG).
Patients and Methods
To determine if the more adult types of cancer that occur in adolescents are better treated at centers with adult oncology expertise, the reported data were re-analyzed according to a scale that assessed whether the type of cancer was more likely to have been treated by oncologists with pediatric versus adult cancer experience.
The results showed that survival hazard index was linearly correlated in 15- to 19-year-olds with the pediatric versus adult cancer type index (P < 0.0001). All of the five most pediatric type of cancers had a better survival at COG institutions and all of the three tumors with a better survival at non-COG institutions had the highest adult type scores.
These results demonstrate that adolescent patients with pediatric types of cancer fare better when their care is conducted or supervised by oncologists who specialize in the care of their type of cancer. The Georgia data are among the first to indicate that the more adult type of cancers are better treated on an adult treatment regimen and/or under the supervision or in conjunction with adult-treating oncologists. Pediatr Blood Cancer 2010;54:238–241. © 2009 Wiley-Liss, Inc.